Stonebridge Capital Management’s Accretive Health AH Stock Holding History

Stonebridge Capital Management’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,614	Closed	-$83K	–	196
2014 Q2	$83K	Sell	10,614 -40,236	-79%	-$315K	0.03%	180
2014 Q1	$407K	Buy	+50,850	New	+$450K	0.17%	124

Other funds holding AH

Neuberger Berman Group

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Accipiter Capital Management Palm Beach Gardens, Florida $124M AUM 6.47% 1-Year Est. Return

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return

Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return

EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Stonebridge Capital Management's AH Position: Q3 2014 in Review

Stonebridge Capital Management sold out of Accretive Health (AH) in Q3 2014, closing a stake of 10,614 shares — an estimated $83K sold.

Stonebridge Capital Management first reported a position in AH in Q1 2014 and held it in 2 quarters. The position peaked at $407K in Q1 2014. 7 funds tracked by Wall St. Rank hold AH as of Q3 2014.

Stonebridge Capital Management reported no remaining Accretive Health position as of Q3 2014 after selling out during the quarter.
Stonebridge Capital Management sold 10,614 Accretive Health shares in Q3 2014, an estimated $83K.
Stonebridge Capital Management first reported a position in Accretive Health in Q1 2014 and held it in 2 quarters.
Stonebridge Capital Management's Accretive Health position peaked at $407K in Q1 2014.
7 funds tracked by Wall St. Rank held Accretive Health as of Q3 2014.

Based on Stonebridge Capital Management's 13F filing for Q3 2014, filed 30 Oct 2014.